Ardavanis, A Tryfonopoulos, D Orfanos, G Karamouzis, M and Scorilas, A Alexopoulos, A Rigatos, G, Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic
chemotherapy in patients with HER2-positive recurrent breast cancer:
Findings from a case series, Onkologie(Czech Republic), (28), 558-564, 2005, Karger,